Hydatid cyst wall antigens [25], hydatid cyst fluid and antigen B [21, 25, 26, 51], EgKI- 1 [23], T. cruzi epimastigote lysates [33], and recombinant T. cruzi calreticulin [77] have exhibited similar promising anti-cancer effects, highlighting their potential as safe therapeutic agents. Here, CALR is linked to cancer.